The SHBG Gene Androgen-Binding Protein Deficiency Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify deficiencies in the Sex Hormone Binding Globulin (SHBG) gene. SHBG plays a critical role in the body by binding to sex hormones, such as testosterone and estrogen, regulating their activity and availability in the bloodstream. A deficiency in the SHBG gene can lead to hormonal imbalances, affecting various bodily functions and potentially contributing to a range of health issues, including fertility problems, metabolic disorders, and hormonal-related diseases.
This genetic test involves analyzing the patient's DNA to detect mutations or abnormalities in the SHBG gene that could lead to a deficiency in the production or function of the SHBG protein. The process is meticulous, requiring a sample of the patient's blood or saliva, which is then examined using advanced genetic sequencing technologies to ensure accurate results.
The cost of the SHBG Gene Androgen-Binding Protein Deficiency Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to conduct the analysis and interpret the results. For individuals experiencing symptoms related to hormonal imbalances or those with a family history of related conditions, this test provides a valuable diagnostic tool, offering insights that can guide treatment decisions and help manage or mitigate the impacts of SHBG gene deficiencies.
The VIPAS39 gene plays a crucial role in the development and function of various body systems. Mutations in this gene are associated with Arthrogryposis-Renal Dysfunction-Cholestasis (ARC) syndrome type 2, a rare genetic disorder. This condition is characterized by joint contractures (arthrogryposis), kidney dysfunction (renal dysfunction), and impaired bile flow from the liver (cholestasis), among other symptoms. Due to the complexity and rarity of ARC syndrome, accurate diagnosis is crucial for appropriate management and treatment.
DNA Labs UAE offers a specialized genetic test targeting the VIPAS39 gene to diagnose Arthrogryposis-Renal Dysfunction-Cholestasis Type 2. The test involves analyzing the patient's DNA to identify mutations in the VIPAS39 gene that are indicative of the syndrome. This genetic test is a vital tool for confirming the diagnosis, which can significantly impact treatment decisions and genetic counseling.
The cost of the VIPAS39 gene test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or cheek swab, and comprehensive analysis by the laboratory. Given the specialized nature of this test and the expertise required to interpret the results accurately, the cost reflects the value of providing a definitive diagnosis for affected individuals and their families.
The BBS1 gene Bardet-Biedl Syndrome Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the BBS1 gene, which are linked to Bardet-Biedl Syndrome (BBS) Type 1. BBS is a rare, genetically inherited disorder characterized by symptoms such as vision loss, kidney dysfunction, obesity, learning disabilities, and extra fingers or toes. Early and accurate diagnosis through genetic testing is crucial for managing the condition and improving the quality of life for affected individuals.
This test specifically looks for alterations in the BBS1 gene, one of the most common genes associated with the condition, to confirm a diagnosis of Bardet-Biedl Syndrome Type 1. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities.
The cost of the BBS1 Gene Bardet-Biedl Syndrome Type 1 Genetic Test at DNA Labs UAE is set at 4400 AED. This cost includes the full process of sample collection, genetic analysis, and the provision of a detailed report by healthcare professionals. The test is an invaluable resource for families with a history of BBS, providing them with essential information for making informed health and lifestyle decisions.
The BBS10 Gene Bardet-Biedl Syndrome Type 10 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the BBS10 gene. This gene is one of the known genetic contributors to Bardet-Biedl Syndrome (BBS), a complex disorder that affects multiple body systems. BBS is characterized by symptoms such as retinal dystrophy, obesity, polydactyly, renal abnormalities, and learning difficulties, among others. The test plays a critical role in the early diagnosis and management of the syndrome, allowing for tailored treatment and intervention strategies.
Performed through a simple blood sample or cheek swab, the test examines the BBS10 gene for specific mutations known to cause the syndrome. The process involves sophisticated genetic sequencing techniques to ensure accurate and reliable results. With a cost of 4400 AED, the test is an investment in the health and well-being of individuals at risk of or suspected to have Bardet-Biedl Syndrome. Early diagnosis through the BBS10 Gene Test can significantly improve the quality of life for affected individuals by enabling proactive management of symptoms and complications associated with the syndrome. DNA Labs UAE stands at the forefront of genetic testing, offering this vital service as part of their comprehensive suite of diagnostic solutions.
The TRIM32 gene Bardet-Biedl Syndrome Type 11 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the TRIM32 gene, which are associated with Bardet-Biedl Syndrome Type 11 (BBS11). Bardet-Biedl Syndrome is a complex genetic disorder that affects multiple body systems, leading to symptoms such as vision loss, kidney dysfunction, obesity, and developmental delays, among others. The TRIM32 gene plays a crucial role in the development and function of cilia, which are microscopic, hair-like structures on cell surfaces that are vital for various cellular processes.
This genetic test is conducted to confirm a clinical diagnosis of BBS11, provide information on the genetic mutation present, and help in understanding the risk of passing the condition to future generations. It is particularly important for families with a history of Bardet-Biedl Syndrome or individuals showing symptoms associated with the disorder.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the TRIM32 gene Bardet-Biedl Syndrome Type 11 genetic test is 4400 AED. DNA Labs UAE employs cutting-edge technology and methodologies to ensure accurate and reliable test results, providing crucial information for patients and healthcare providers for the management and treatment of Bardet-Biedl Syndrome.
The NR3C2 Gene Hypertension Early Onset Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the NR3C2 gene, which have been associated with early-onset hypertension. Hypertension, or high blood pressure, is a common condition that can lead to serious health issues such as heart disease, stroke, and kidney failure. Early detection through genetic testing can be crucial in managing and potentially mitigating the risks associated with this condition.
The NR3C2 gene plays a significant role in the body's regulation of sodium reabsorption in the kidneys, which in turn affects blood pressure. Mutations in this gene can disrupt normal function, leading to an increased risk of developing hypertension at an early age. By identifying individuals with these genetic mutations, healthcare providers can implement early intervention strategies, including lifestyle modifications and targeted therapies, to reduce the risk of hypertension-related complications.
The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations in the NR3C2 gene. Results from this test can provide valuable insights into an individual's risk of developing early-onset hypertension, enabling personalized medical care and preventive measures.
Given the potential health implications of early-onset hypertension, the NR3C2 Gene Hypertension Early Onset Genetic Test is a valuable tool for individuals with a family history of hypertension or those who have early signs of high blood pressure. It represents a proactive approach to health management, emphasizing the importance of genetic factors in understanding and treating hypertension.
The ADD2 gene, also known as Adducin 2, plays a crucial role in the regulation of blood pressure and has been linked to the development of hypertension. Genetic variations in the ADD2 gene can influence the risk of developing hypertension, a condition characterized by persistently high blood pressure that can lead to serious health complications such as heart disease, stroke, and kidney failure.
DNA Labs UAE offers a specialized genetic test aimed at identifying variations in the ADD2 gene that are associated with an increased risk of hypertension. This test is designed for individuals who may have a family history of hypertension or have been diagnosed with the condition and wish to understand their genetic predisposition. By analyzing specific markers within the ADD2 gene, the test can provide valuable insights into a person's genetic risk of developing hypertension, which can be crucial for early intervention and management of the condition.
The cost of the ADD2-related genetic test at DNA Labs UAE is 4400 AED. The testing process involves collecting a DNA sample, typically through a simple and non-invasive saliva or blood sample. The sample is then analyzed in the laboratory to identify any genetic variations in the ADD2 gene. Results from the test can help healthcare providers tailor treatment and prevention strategies more effectively, potentially reducing the risk of complications associated with hypertension.
Individuals interested in undergoing the ADD2 gene hypertension-related genetic test at DNA Labs UAE are advised to consult with their healthcare provider to discuss the potential benefits and implications of the test based on their personal health history and risk factors.
The CYP3A5 gene plays a crucial role in the metabolism of various substances within the body, including certain medications and steroids. Its expression can significantly influence an individual's response to drugs and susceptibility to certain conditions, including salt-sensitive essential hypertension. Salt-sensitive hypertension is a condition where blood pressure increases significantly in response to salt intake. Individuals with certain variations in the CYP3A5 gene may have an increased risk of developing this type of hypertension, highlighting the importance of genetic factors in understanding individual health risks.
To assess the risk of developing salt-sensitive essential hypertension and tailor preventive or therapeutic strategies accordingly, a genetic test targeting the CYP3A5 gene can be performed. This test can identify specific variants of the CYP3A5 gene that are associated with an increased susceptibility to salt-sensitive hypertension. By understanding an individual's genetic makeup, healthcare providers can offer personalized advice on diet, lifestyle changes, and, if necessary, medication to manage blood pressure effectively.
In the UAE, DNA Labs offers this specialized genetic test for individuals concerned about their risk of developing salt-sensitive essential hypertension. The test costs 4400 AED and provides valuable insights into one's genetic predisposition to this condition. Conducted in a state-of-the-art laboratory by experienced professionals, the test involves a simple and non-invasive sample collection process, with results typically available within a few weeks. These results can then be used to inform lifestyle adjustments and healthcare decisions, potentially reducing the risk of hypertension-related complications.
The NOS2 gene, known for its role in nitric oxide production, has been linked to the susceptibility of developing hypertension, a condition characterized by high blood pressure that can lead to severe health issues such as heart disease, stroke, and kidney problems. Genetic testing for NOS2 gene variants can provide valuable insights into an individual's risk of developing hypertension, enabling early intervention and personalized management strategies to mitigate this risk.
At DNA Labs UAE, a specialized test is available to analyze the NOS2 gene for specific variants associated with hypertension susceptibility. This test is a crucial tool for individuals with a family history of hypertension or those who wish to understand their genetic predisposition to this condition. By identifying the presence of certain genetic markers, healthcare providers can tailor prevention and treatment plans more effectively.
The cost of the NOS2 gene hypertension susceptibility genetic test at DNA Labs UAE is 4400 AED. This investment can be invaluable for individuals seeking to take proactive steps in managing their health and preventing the onset of hypertension. The test is conducted under strict laboratory conditions, ensuring accuracy and reliability of the results, which are typically available within a few weeks. With this information, individuals and their healthcare providers can work together to develop lifestyle and medical interventions that significantly reduce the risk of developing hypertension.
The TGFB2 gene plays a crucial role in the development and maintenance of body tissues. Mutations in this gene are associated with Loeys-Dietz syndrome type 4, a rare genetic disorder characterized by vascular, skeletal, and cutaneous abnormalities. This condition can lead to life-threatening complications such as aortic aneurysms.
The TGFB2 Gene Loeys-Dietz Syndrome Type 4 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the TGFB2 gene. By analyzing a sample of the patient's DNA, this test can confirm a diagnosis of Loeys-Dietz syndrome type 4, enabling timely and appropriate medical intervention. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the presence of the specific genetic alterations associated with this condition. Undergoing this test at DNA Labs UAE ensures access to leading genetic testing services in the region, providing patients and their families with crucial information for managing the syndrome effectively.
